Elanco Animal Health Inc (ELAN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 338,000 | -1,231,000 | -78,000 | -483,000 | -574,000 |
| Depreciation Amortization | 662,000 | 694,000 | 682,000 | 716,000 | 517,000 |
| Income taxes - deferred | -112,000 | -80,000 | -57,000 | -148,000 | -114,000 |
| Accounts receivable | 12,000 | -40,000 | 14,000 | -35,000 | 24,000 |
| Accounts payable and accrued liabilities | 82,000 | -94,000 | -98,000 | -116,000 | 362,000 |
| Other Working Capital | 149,000 | -300,000 | -462,000 | -88,000 | 169,000 |
| Other Operating Activity | -590,000 | 1,322,000 | 451,000 | 637,000 | -425,000 |
| Operating Cash Flow | $541,000 | $271,000 | $452,000 | $483,000 | $-41,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -147,000 | -140,000 | -171,000 | -159,000 | -63,000 |
| Net Acquisitions | 1,253,000 | -19,000 | N/A | -342,000 | -4,566,000 |
| Purchase Sale Intangibles | -14,000 | -14,000 | -13,000 | -38,000 | -176,000 |
| Other Investing Activity | 52,000 | -10,000 | -8,000 | -29,000 | -150,000 |
| Investing Cash Flow | $1,158,000 | $-169,000 | $-179,000 | $-530,000 | $-4,779,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 570,000 | 600,000 | 988,000 | 1,000,000 | 4,804,000 |
| Debt Repayment | -2,045,000 | -677,000 | -1,490,000 | -823,000 | -952,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 1,220,000 |
| Other Financing Activity | -17,000 | -6,000 | -47,000 | 33,000 | -118,000 |
| Financing Cash Flow | $-1,492,000 | $-83,000 | $-549,000 | $210,000 | $4,954,000 |
| Exchange Rate Effect | -91,000 | -12,000 | -17,000 | -31,000 | 27,000 |
| Beginning Cash Position | 352,000 | 345,000 | 638,000 | 506,000 | 345,000 |
| End Cash Position | 468,000 | 352,000 | 345,000 | 638,000 | 506,000 |
| Net Cash Flow | $116,000 | $7,000 | $-293,000 | $132,000 | $161,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 541,000 | 271,000 | 452,000 | 483,000 | -41,000 |
| Capital Expenditure | -147,000 | -140,000 | -171,000 | -159,000 | -135,000 |
| Free Cash Flow | 394,000 | 131,000 | 281,000 | 324,000 | -176,000 |